Approval · Notice of Compliance 26112 · 2021
TIROCAP: Notice of Compliance 26112
Issued June 21, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26112
- Date
- June 21, 2021
- Company
- Ibsa Institut Biochimique SaPazzallo, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Product name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIROCAP | 02508486 | Cancelled Pre Market |
| TIROCAP | 02508494 | Cancelled Pre Market |
| TIROCAP | 02508508 | Cancelled Pre Market |
| TIROCAP | 02508516 | Cancelled Pre Market |
| TIROCAP | 02508524 | Cancelled Pre Market |
| TIROCAP | 02508532 | Cancelled Pre Market |
| TIROCAP | 02508540 | Cancelled Pre Market |
| TIROCAP | 02508559 | Cancelled Pre Market |
| TIROCAP | 02508567 | Cancelled Pre Market |
| TIROCAP | 02508575 | Cancelled Pre Market |
| TIROCAP | 02508583 | Cancelled Pre Market |
| TIROCAP | 02508591 | Cancelled Pre Market |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 13 MCG per CAP
- LEVOTHYROXINE SODIUM 25 MCG per CAP
- LEVOTHYROXINE SODIUM 50 MCG per CAP
- LEVOTHYROXINE SODIUM 75 MCG per CAP
- LEVOTHYROXINE SODIUM 88 MCG per CAP
- LEVOTHYROXINE SODIUM 100 MCG per CAP
- LEVOTHYROXINE SODIUM 112 MCG per CAP
- LEVOTHYROXINE SODIUM 125 MCG per CAP
- LEVOTHYROXINE SODIUM 137 MCG per CAP
- LEVOTHYROXINE SODIUM 150 MCG per CAP
- LEVOTHYROXINE SODIUM 175 MCG per CAP
- LEVOTHYROXINE SODIUM 200 MCG per CAP